Abbratech, Inc.
Publicly observedBranford, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Branford | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Abbratech, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | G7S7M6L41EX5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant20 Sept 2024Publicly observed
NIH SBIR/STTR award: DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE Abs
USD 301,174.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2024Publicly observed
NIH SBIR/STTR award: DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE Abs
USD 551,373.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2023Publicly observed
NIH SBIR/STTR award: A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
USD 1.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.